Biological properties of the pathogen
Clostridium difficile is a large Gram-positive bacillus. The bacterium is motile due to numerous flagella distributed over the entire cell surface (peritrichous). Under conditions unfavorable for the vegetative form, it is capable of forming oval subterminal spores. These spores are remarkably resistant: in the environment (in soil, water, or animal feces), they remain viable for 110 to 180 days, and they also easily withstand high concentrations of antibiotics in the intestine.
By type of respiration, the microbe is an obligate anaerobe, meaning oxygen is toxic to it. When cultured in laboratory conditions, the bacterium grows well on blood agar. Its biochemical activity is relatively low. Metabolism is based on the fermentation of carbohydrates and proteins, with various fatty acids (acetic, butyric, isobutyric, isocaproic, and isovaleric) serving as the end products of metabolism.
Pathogenicity factors and pathogenesis
The pathogenic potential of C. difficile is entirely due to its ability to secrete dangerous exotoxins into the intestinal lumen. Two key substances play the primary role:
- Toxin A (enterotoxin): stimulates massive fluid secretion into the intestinal lumen, leading to profuse diarrhea.
- Toxin B (cytotoxin): directly destroys enterocyte cell membranes and inhibits intracellular protein synthesis, causing tissue necrosis.
The triggering factor for the infection is almost always the administration of antibacterial drugs. Medications destroy the beneficial obligate microflora, which normally suppresses pathogen growth. Having obtained an open ecological niche, opportunistic C. difficile begins to multiply rapidly and release toxins. As a result, specific deposits of mucus, fibrin, and dead cells—pseudomembranes—form on the damaged mucosa of the large intestine.
Epidemiology and Clinical Presentation
The pathogen is classified as an opportunistic bacterium. In approximately 2–5% of completely healthy individuals, C. difficile peacefully resides in the intestine as transient microflora (bacterial carriage). The infection is transmitted via the fecal-oral mechanism. The main sources of infection are sick individuals or asymptomatic carriers.
The disease occurs in the form of an acute infection—enteral clostridiosis. The classic clinical presentation includes a triad of symptoms:
- Pronounced toxemia (weakness, fever).
- Acute diarrheal syndrome (frequent, watery stools).
- Development of pseudomembranous colitis with cramping abdominal pain.
Note: in addition to intestinal lesions, this clostridial species can occasionally participate in the development of purulent-inflammatory processes and even gas gangrene.
Microbiological diagnostics and treatment
The primary clinical specimen for investigation is the patient's feces. Three groups of methods are used in the laboratory:
- Immunochemical (ELISA): allows direct detection of toxins A and B in stool. This is a crucial step, as the mere presence of the bacterium without toxin production does not confirm the disease.
- Bacteriological: inoculation of the specimen onto selective nutrient media with isolation of a pure culture. After cultivation, the strain is obligatorily tested for toxigenicity.
- Molecular genetic: PCR for the rapid detection of specific DNA segments of the pathogen.
Etiotropic treatment requires immediate discontinuation of the antibiotic that provoked the dysbiosis and the prescription of drugs that specifically target clostridia—vancomycin or metronidazole. Probiotics have proven effective as adjunctive restorative therapy. There is no specific prevention (vaccine) against the infection, so rational antibiotic therapy and strict adherence to sanitary and hygienic regimens in hospitals come to the forefront.
Briefly: answers to topical questions
Which antibiotic groups most frequently provoke the development of pseudomembranous colitis?
The development of the disease is most frequently provoked by systemic antibiotics that directly disrupt the composition of the intestinal microbiota. The following groups of drugs are distinguished by risk level:
- Highest risk — clindamycin, beta-lactam antibiotics (penicillins, third- and fourth-generation cephalosporins, carbapenems), and fluoroquinolones.
- Moderate risk — macrolides, sulfonamides, and trimethoprim.
The risk of developing the infection is directly proportional to the duration of administration and the number of prescribed drugs.
What pathogenicity factors of Clostridium difficile exist besides exotoxins A and B?
The sources mention genes encoding binary toxin and glutamate dehydrogenase (GDH). However, the sources do not confirm that binary toxin belongs to established pathogenicity factors, nor do they classify GDH as a pathogenicity factor. Plasmids of adhesiveness and enterotoxigenicity are cited for bacteria in general, without a direct link to Clostridium difficile.
What are the rules for collecting and transporting feces for Clostridium difficile diagnostics?
For microbiological diagnostics, the patient's feces are collected. The interval between sample collection and inoculation must not exceed 1–2 hours to prevent putrefactive processes and the proliferation of rapidly growing accompanying flora. Transportation must be carried out using airtight containers, tubes, or transport systems with nutrient media. Since the pathogen is an obligate anaerobe, vessels with inert gas or methods completely excluding aeration are used to maintain its viability.
What life-threatening complications can develop in severe cases of pseudomembranous colitis?
In severe pseudomembranous colitis, the following life-threatening conditions may develop:
- Intestinal complications — toxic megacolon, ileus (intestinal paresis), intestinal bleeding, colonic perforation, and peritonitis.
- Systemic complications — electrolyte disturbances, renal failure, systemic inflammatory response syndrome (SIRS), septicemia, and septic shock.
The fulminant form may also be accompanied by severe hypotension, altered mental status, and ultimately lead to a fatal outcome.
Remembering the functions of the toxins is simple: A — Attacks with fluid (enterotoxin, causes watery diarrhea), B — Breaks cells (cytotoxin, destroys enterocyte membranes).
Class and exam questions
Why does clostridiosis develop specifically after a course of antibiotics?
Broad-spectrum antibacterial drugs destroy the normal intestinal microflora. The vacated ecological niche allows resistant C. difficile spores to germinate and begin active toxin production without competition from beneficial bacteria.
How is this infection transmitted?
The primary transmission mechanism is fecal-oral. Bacterial spores can persist for a long time on surfaces in hospital rooms, on the hands of medical personnel, as well as in soil and water.
Why test a pure culture for toxigenicity when it is isolated?
Up to 5% of people are asymptomatic carriers of non-toxigenic C. difficile strains. The disease (pseudomembranous colitis) is caused only by those bacteria that are capable of producing exotoxins A and B.
What else to study on this topic
- Features of cultivating obligate anaerobes in laboratory conditions
- Pathomorphology and endoscopic picture of pseudomembranous colitis
- Mechanisms of bacterial spore resistance
- The role of probiotics in restoring the intestinal microbiome
- Differential diagnosis of clostridial infections
Study the full topic in the «Microbiology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Clostridium difficile" and 4,383 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 141 video lectures on the subject
Other topics in the section "Gram-positive spore-forming bacilli (Anthrax, Clostridia: tetanus, botulism, gas gangrene, difficile)"
Free video lessons: microbiologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.